Unknown

Dataset Information

0

In vitro assessment of triterpenoids NVX-207 and betulinyl-bis-sulfamate as a topical treatment for equine skin cancer.


ABSTRACT: Equine sarcoid (ES) is the most prevalent skin tumor in equids worldwide. Additionally, aging grey horses frequently suffer from equine malignant melanoma (EMM). Current local therapies targeting these skin tumors remain challenging. Therefore, more feasible topical treatment options should be considered. In order to develop a topical therapy against ES and EMM, betulinyl-bis-sulfamate and NVX-207, derivatives of the naturally occurring betulin and betulinic acid, respectively, were evaluated for their antiproliferative (crystal violet staining assay), cytotoxic (MTS assay) and apoptotic (AnnexinV staining, cell cycle investigations) effects on primary ES cells, EMM cells and equine dermal fibroblasts in vitro. The more potent derivative was assessed for its in vitro penetration and permeation on isolated equine skin within 30 min and 24 h using Franz-type diffusion cells and HPLC analysis. Betulinyl-bis-sulfamate and NVX-207 inhibited the proliferation and metabolism in ES cells, EMM cells and fibroblasts significantly (p < 0.001) in a time- and dose-dependent manner. NVX-207 had superior anticancer effects compared to betulinyl-bis-sulfamate. Both compounds led to the externalization of phosphatidylserines on the cell membrane and DNA fragmentation, demonstrating that the effective mode of action was apoptosis. After 48 h of treatment with NVX-207, the number of necrotic cells was less than 2% in all cell types. Detected amounts of NVX-207 in the different skin layers exceeded the half-maximal inhibitory concentrations calculated by far. Even though data obtained in vitro are auspicious, the results are not unconditionally applicable to the clinical situation. Consequently, in vivo studies are required to address the antitumoral effects of topically applied NVX-207 in ES and EMM patients.

SUBMITTER: Weber LA 

PROVIDER: S-EPMC7643960 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

In vitro assessment of triterpenoids NVX-207 and betulinyl-bis-sulfamate as a topical treatment for equine skin cancer.

Weber Lisa Annabel LA   Funtan Anne A   Paschke Reinhard R   Delarocque Julien J   Kalbitz Jutta J   Meißner Jessica J   Feige Karsten K   Kietzmann Manfred M   Cavalleri Jessika-Maximiliane V JV  

PloS one 20201105 11


Equine sarcoid (ES) is the most prevalent skin tumor in equids worldwide. Additionally, aging grey horses frequently suffer from equine malignant melanoma (EMM). Current local therapies targeting these skin tumors remain challenging. Therefore, more feasible topical treatment options should be considered. In order to develop a topical therapy against ES and EMM, betulinyl-bis-sulfamate and NVX-207, derivatives of the naturally occurring betulin and betulinic acid, respectively, were evaluated fo  ...[more]

Similar Datasets

| S-EPMC8614291 | biostudies-literature
| S-EPMC10752953 | biostudies-literature
| S-EPMC9026853 | biostudies-literature
| S-EPMC7987642 | biostudies-literature
| S-EPMC8877452 | biostudies-literature
| S-EPMC5478660 | biostudies-literature
| S-EPMC4002699 | biostudies-other
| S-EPMC5874840 | biostudies-other
| S-EPMC8360843 | biostudies-literature
| S-EPMC7070905 | biostudies-literature